# NIH Reporter #3K23AI182453-03S1

The development & pilot implementation of a CRISPR-based low-cost point-of-care assay for detecting Neisseria gonorrhoeae and molecular markers of antimicrobial resistance in resource-limited settings

**Recipient:** Lao-Tzu Allan-Blitz

**Award Amount:** $43,171.00
**Ceiling:** $43,171.00

**Awarded:** September 17, 2026

**Identifier:** 3K23AI182453-03S1

Award to develop and pilot a CRISPR-based assay for detecting Neisseria gonorrhoeae and antimicrobial resistance in resource-limited settings, supporting career development of Dr. Lao-Tzu Allan-Blitz.

### Description

This project aims to develop and evaluate a CRISPR-based low-cost point-of-care assay for detecting Neisseria gonorrhoeae and antimicrobial resistance markers, with a focus on resource-limited settings such as Botswana. The award supports Dr. Lao-Tzu Allan-Blitz’s career development in STI assay development and implementation.

[View original record](https://reporter.nih.gov/search/IgE1H2ioLUOz0qmA4MDg0Q/project-details/11621917)